Search research articles
Contact Us
Filters
Showing results (291-300 of 525) with videos related to
Page
of 53
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
November 1, 2024
Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns
Avy Violari, Kennedy Otwombe, William Hahn, et al.
Nature Immunology
|
September 24, 2021
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination
Jeffrey Alan Tomalka, Adam Nicolas Pelletier, Slim Fourati, et al.
Cell
|
October 2, 2018
RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses
Todd Bradley, Dimitra Peppa, Isabela Pedroza-Pacheco, et al.
Virology
|
September 12, 2009
Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins
Feng Gao, Richard M Scearce, S Munir Alam, et al.
Journal of Virology
|
September 26, 2008
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
James M Binley, Elizabeth A Lybarger, Emma T Crooks, et al.
Vaccine
|
March 19, 2023
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial
Gregory J Wilson, Benigno Rodriguez, Shuying Sue Li, et al.
Nature Medicine
|
September 5, 2018
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV
Margaret E Ackerman, Jishnu Das, Srivamshi Pittala, et al.
Scientific Reports
|
February 9, 2020
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens
Xiaoying Shen, Fatima Laher, Zoe Moodie, et al.
Mucosal Immunology
|
August 8, 2014
Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women
C R Sacha, N Vandergrift, T L Jeffries, et al.
Plos One
|
March 15, 2014
DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques
Rashmi Jalah, Viraj Kulkarni, Vainav Patel, et al.
Page
of 53
Search research articles
Search
Showing results (291-300 of 525) with videos related to
Sort By:
Page
of 53
Medrxiv : the Preprint Server for Health Sciences
|
November 1, 2024
Safety and implementation of a phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns
Avy Violari, Kennedy Otwombe, William Hahn, et al.
Nature Immunology
|
September 24, 2021
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination
Jeffrey Alan Tomalka, Adam Nicolas Pelletier, Slim Fourati, et al.
Cell
|
October 2, 2018
RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses
Todd Bradley, Dimitra Peppa, Isabela Pedroza-Pacheco, et al.
Virology
|
September 12, 2009
Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins
Feng Gao, Richard M Scearce, S Munir Alam, et al.
Journal of Virology
|
September 26, 2008
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C
James M Binley, Elizabeth A Lybarger, Emma T Crooks, et al.
Vaccine
|
March 19, 2023
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial
Gregory J Wilson, Benigno Rodriguez, Shuying Sue Li, et al.
Nature Medicine
|
September 5, 2018
Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV
Margaret E Ackerman, Jishnu Das, Srivamshi Pittala, et al.
Scientific Reports
|
February 9, 2020
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens
Xiaoying Shen, Fatima Laher, Zoe Moodie, et al.
Mucosal Immunology
|
August 8, 2014
Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women
C R Sacha, N Vandergrift, T L Jeffries, et al.
Plos One
|
March 15, 2014
DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques
Rashmi Jalah, Viraj Kulkarni, Vainav Patel, et al.
Page
of 53